Staging and management of stage-3 non-small cell lung cancer - 9 FEBRUARY, 2026

Taking place on 9 February, this instalment will feature an expert panel discussing staging and management of stage-3 non-small cell lung cancer.

Topics:

Andriani is an Associate Professor in Thoracic Oncology and Head of the Clinical Research Department at the Oncology Unit of the 3^rd Internal Medicine Clinic and Laboratory of the Medical School of the National and Kapodistrian University of Athens.
She has been highly involved with ERS since 2002 and is a member of its College of Experts.
She has organised an ERS Skills Course on the Multidisciplinary Approach of Lung, and she is the Chair of the Lung Cancer Group (11.1) in the Thoracic Oncology Assembly of ERS.
Her special interests are translational cancer research and clinical trials.

Suresh is a radiation oncologist at the Amsterdam University Medical Centers in The Netherlands.
His research has mainly focused on clinical trials in lung cancer, including use of immune checkpoint inhibitors, in implementing new radiotherapy technologies and comparative effectiveness research.
He is a faculty member for thoracic malignancies at the European Society of Medical Oncology, editorial member at the International Association for the Study of Lung Cancer newsletter, and teaching faculty for the Image-guided SBRT course conducted by the European Society for Radiation Oncology.

Mohammed has been a Consultant Chest Physician/ Interventional Pulmonologist at Lancashire Teaching Hospitals, Preston, UK for over 26 years.
He is also Honorary Clinical Professor, University of Central Lancashire and Honorary Senior Lecturer, University of Manchester.
Amongst many leadership positions he is the current Head of ERS Assembly 14: Clinical techniques, imaging and endoscopy, past-chair of Interventional Pulmonology for ERS (2021-2024), and immediate Past President of the European Association of Bronchology and Interventional Pulmonology.
He is actively involved in the evaluation of innovative techniques/tools in thoracoscopy/bronchoscopy.

Kalliopi is a senior consultant thoracic surgeon at General Hospital "EVANGELISMOS" in Greece.
She was elected president of the Hellenic Society of Thoracic-Cardiac-Vascular Surgeons and actively participates in European Societies.
Kalliopi has been Regent of Greece and member of the Council of the European Society of Thoracic Surgeons, member of the Thoracic Committee of the European Association of Cardiothoracic Surgery, co-founder of the European School (EACTS Academy), coordinator of the Thoracic Surgery Course and former general secretary of the Thoracic Group of ERS.
Currently she is chair of the Thoracic surgery Group of ERS (8.01).

Dirk is a full Professor of Radiation Oncology/ Respiratory Oncology both at the Maastricht University Medical Center, Maastricht, and at Erasmus MC, Rotterdam, The Netherlands.
He is head of the Division Maastro Clinical Research, chairs the EORTC Lung Cancer Group/Oligometastatic and new development group and was the former chair of DUPROTON (the Dutch organisation for proton therapy research) and of the Dutch Platform for Radiotherapy of Lung Cancer.
He is the coordinator of the biobank project at Maastro Clinic that was able to include about 10,000 patients for radiogenomic studies.
He has published predictive models for survival and toxicity, on radiogenomics and Artificial Intelligence for predicting tumor response on chemo-immunotherapy and to distinguish auto-immune from other forms of pneumonitis.

#{title}